Confronting the Burden of Serious Infections: Managed Care Considerations in an Evolving Treatment Landscape

A continuing medical education activity sponsored by NAMCP and AAMCN 

Confronting the Burden of Serious Infections: Managed Care Considerations in an Evolving Treatment Landscape is a 3-part webcast series that will provide critical updates on the advances of antimicrobial use in serious infections, including how to translate the most recent data into clinical and administrative practice.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in all 3 or in order.

These are archives of live webinars held between August 27 and September 12, 2019.

If you participated in any of the live webinars, you are not eligible to claim credit from the archive of that webinar.

Each session has its own specific valid dates

This series is supported by an educational grant from Merck Sharp & Dohme Corp.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.  

 To print or save your certificate, you will need to click on the “download” button and either print or save.

You may view the presentations either in HTML5 or Adobe Flash Player 
The presentations in Flash require Adobe Flash Player.  You can download it here.

Infections caused by Gram-negative bacteria, C. Difficile bacterium, and Cytomegalovirus (CMV) are a significant concern and can have serious consequences. These infections are increasing in prevalence, and their management is complicated by limited treatment options. New clinical practice guidelines are out and clinical best practices for optimal treatment of these challenging clinical situations will be discussed by experts in the infectious disease field, within the wider clinical context of responsible antimicrobial stewardship and managed care decision making. Each webinar will offer a new, specific view into the evolving management paradigm of serious infections, especially as it relates to overcoming barriers found amongst clinicians and managed care professionals.

Overcoming Challenges in the Treatment and Management of Cytomegalovirus
  1. Describe the clinical and economic burden of Cytomegalovirus (CMV) in HSCT patients and the impact of these burdens on optimalmanagement
  2. Examine prophylactic measures for CMV in patients undergoing HSCT using evidence-based therapeutic approaches
  3. Analyze the efficacy and safety of available and emerging treatment strategies for prevention of recurrent CMV in patients undergoing HSCT based on evidence-based therapeutic approaches
  4. Identify patients who may benefit from antiviral treatment for CMV infection
  5. Optimize clinical and economic strategies in the prevention of CMV in HSCT recipients
       Physician, Nursing and CMCN credits valid to October 1, 2021


Novel Approaches in the Management of Clostridium Difficile Infection
  1. Analyze the recently updated IDSA and SHEA clinical practice guidelines for the management of Clostridium difficile infection (CDI)
  2. Discuss how changes to the clinical practice guidelines will change management in CDI
  3. Differentiate current antibiotic treatments for CDI by their cure rates, effects on microbiota colonization, and efficacy in reducing recurrent infection
  4. Apply practice guidelines and evidence from clinical trials and studies to inform managed care decisions for reducing C. diff recurrence and managing recurrent episodes
  5. Discuss treatment of CDI with a focus on sustained clinical response
       Physician, Nursing and CMCN credits valid to October 1, 2021


New Developments in the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
  1. Explore the evolving prevalence and etiology of gram-negative bacteria and their impact on the spectrum of serious nosocomial infections
  2. Compare and contrast efficacy and safety of new and emerging antibacterial treatments for serious infections caused by gram-negative bacteria, including hospital-acquired/ventilator-associated bacterial pneumonia and other complicated infections
  3. Explain the evidence and utility of new antibacterial therapies for multidrug resistant gram-negative bacterial infections
  4. Outline patient and clinical factors that increase risks for resistant Gram-negative pathogens
  5. Optimize clinical and economic strategies in the management of serious Gram-negative infections
       Physician, Nursing and CMCN credits valid to October 1, 2021